eGenesis
The Senior Research Associate supports preclinical and translational science by executing and owning immunological assays for xenotransplantation products. This role focuses on delivering reliable flow cytometry-based screening results to inform patient selection and monitoring, involving significant cell culture work with porcine, non-human primate, and human samples. The position requires strong flow cytometry expertise and close coordination with clinical and cross-functional partners to ensure timely and accurate results.
Headquarters
Cambridge, Massachusetts, United States
Company Size
51-200 employees
Founded
2015
eGenesis is a biotechnology company developing gene-edited organ and cell therapies for transplantation, with a focus on xenotransplantation using engineered pig organs and tissues.
FDA greenlights trial of gene-edited pig kidneys as treatment for end-stage kidney disease
Sep 8, 2025
Scientists Grow More Hopeful About Ending a Global Organ Shortage
Nov 12, 2025
eGenesis Secures IND Clearance for EGEN-2784 in Kidney Transplant and Reports Significant Patient Progress
Sep 9, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for eGenesis.
eGenesis to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan 7, 2026